# Sitagliptin in Type I Diabetic Patients

> **NCT01741103** · NA · WITHDRAWN · sponsor: **University at Buffalo**

## Conditions studied

- Diabetes Type I

## Interventions

- **DRUG:** sitagliptin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01741103
- **Lead sponsor:** University at Buffalo
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-06
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study funding was for 1 year to a fellow who graduated in early stages of enrollment. While 6 patients were enrolled, many patients didn't finish the study and therefore little data was collected and no results will be entered.
- **Last updated:** 2022-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01741103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01741103, "Sitagliptin in Type I Diabetic Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01741103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*